Conference
2nd Cell & Gene Therapy Global Congress 2024 Europe
Oct 03 - 04, 2024
London, UK
The Global Summit on Cell and Gene Therapy serves
as a pivotal gathering for industry leaders, researchers, and innovators to
discuss the latest advancements in this rapidly evolving field. With a focus on
cutting-edge research, regulatory updates, and collaborative opportunities,
attendees can expect insightful discussions that drive the future of
healthcare.
The summit will feature expert speakers, interactive
sessions, and networking opportunities designed to foster collaboration and
innovation. Participants will gain valuable insights into the challenges and
breakthroughs shaping cell and gene therapy, equipping them with the knowledge
needed to navigate this complex landscape effectively.
Stay ahead in the Pharma game
Register for this event now!
Speaker line up
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
About the Organiser
Paradigm Global Events (PGE)
London, UK
Paradigm Global Events specializes in organizing innovative,
research-driven conferences and networking events across various industries,
including pharmaceuticals, renewable energy, and logistics. Their events aim to
facilitate knowledge sharing among senior decision-makers, showcasing emerging
trends, technologies, and solutions. With a focus on creating high-value
partnerships, Paradigm provides a platform for companies to connect, learn, and
thrive in an evolving marketplace.
Day and Timing
Thursday, Oct 3 - 4
Location
London, UK
Entry Fees
Paid
Frequency
Annual
Event Type
Conference
Duration
2 Days
Website
cell-genetherapy.com
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news
Stay ahead in the Pharma game
Register for this event now!
Day and Timing
Thursday, Oct 3 - 4
Location
London, UK
Entry Fees
Paid
Frequency
Annual
Event Type
Conference
Duration
2 Days
Website
cell-genetherapy.comSpeaker line up
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
Adam Glen
Unicorn Bio
Co-founder
Alberto Malerba
Royal Holloway University of London
Lecturer in Gene Therapy
Alex Blyth
Lift Biosciences
Founder & CEO
Alexander Natz
EUCOPE
Secretary General
Amir Hefni
Novartis
Global Head, Cell & Gene Therapy
Ben Doak
NHS England
Head of Innovative Treatments
Cecilia Gotherstrom
Karolinska Institute
Research Group leader, Associate Professor in Stem Cell Science
Daniel Gibson
Anthony Nolan
Director of Cell and Gene
Dilip Patel
Autolus
VP, Head of Global Market Access
Doug Danison
Bayer
Head of Commercial, Cell and Gene Therapy Unit
Dr Lilian Hook
NHS Blood and Transplant
Director Cell, Apheresis & Gene Therapies
Dr Nagy Habib
Imperial College London
Professor of Surgery
Dr Theres Oakes
Achilles Therapeutics
Head of Product Characterisation
Dr. Chris Williams
Autolus Ltd.
SVP Corporate Development
Dr. Ron Jortner
Aspire Biosciences
Founder/CEO
Dr. Thomas Schochat
Swissmedic
Clinical Assessor, Division Advanced Therapy Products
Eric Halioua
PDC*line Pharma
President & Chief Executive Officer
Eugean Jiwanmall
Independence Blue Cross
Senior Research Analyst
Jeff Liter
OX2 Therapeutics
CEO
Julia Djonova
Swissmedic
Head, Advanced Therapy Medicinal Products
Manal Morsy
Athersys, Inc
EVP, Head of Global Regulatory Affairs
Marco Traub
The Trans European Stem Cell Therapy Society
CEO
Matthias Bozza
Vector BioPharma
Director
Mohamed Oubihi
YAKUMED LIMITED
Founder and CEO
Prof Harris Makatsoris
Department of Engineering, King’s College
Professor of Manufacturing Systems
Reagan Jarvis
Anocca
Chief Executive Officer and Co-founder
Stuart M Curbishley
adthera bio
Chief Manufacturing and Chief Development Officer
Thomas Mueller
Federal Ministry of Health Germany
Head Of Directorate General
About the Organiser
Paradigm Global Events (PGE)
London, UK
Paradigm Global Events specializes in organizing innovative,
research-driven conferences and networking events across various industries,
including pharmaceuticals, renewable energy, and logistics. Their events aim to
facilitate knowledge sharing among senior decision-makers, showcasing emerging
trends, technologies, and solutions. With a focus on creating high-value
partnerships, Paradigm provides a platform for companies to connect, learn, and
thrive in an evolving marketplace.
More Events
Conference
6th Annual Pharma Manufacturing and Automation Convention 2024
Oct 17 - 18, 2024
Hyderabad, India
Conference
19th International Conference of Drug Regulatory Authorities
Oct 14 - 18, 2024
New Delhi, India
Conference
The Pharma Industry CEO Conclave
Oct 19 - 19, 2024
Pune, India
View All
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news